IE52535B1
(en)
*
|
1981-02-16 |
1987-12-09 |
Ici Plc |
Continuous release pharmaceutical compositions
|
FR2537980B1
(fr)
*
|
1982-12-17 |
1986-12-19 |
Sandoz Sa |
Derives d'acides hydroxycarboxyliques oligomeres, leur preparation et leur utilisation
|
AU567155B2
(en)
*
|
1983-04-15 |
1987-11-12 |
Damon Biotech Inc. |
Capsules for releasing core material at constant rate
|
US4652443A
(en)
*
|
1983-06-07 |
1987-03-24 |
Japan Atomic Energy Research Institute |
Slow-release composite and process for producing the same
|
CH661206A5
(fr)
*
|
1983-09-23 |
1987-07-15 |
Debiopharm Sa |
Procede pour la preparation d'un medicament destine au traitement de maladies hormonodependantes.
|
JPS60100516A
(ja)
*
|
1983-11-04 |
1985-06-04 |
Takeda Chem Ind Ltd |
徐放型マイクロカプセルの製造法
|
US6410056B1
(en)
|
1984-03-16 |
2002-06-25 |
The United States Of America As Represented By The Secretary Of The Army |
Chemotherapeutic treatment of bacterial infections with an antibiotic encapsulated within a biodegradable polymeric matrix
|
US5693343A
(en)
|
1984-03-16 |
1997-12-02 |
The United States Of America As Represented By The Secretary Of The Army |
Microparticle carriers of maximal uptake capacity by both M cells and non-M cells
|
USRE40786E1
(en)
|
1984-03-16 |
2009-06-23 |
The United States Of America As Represented By The Secretary Of The Army |
Vaccines against intracellular pathogens using antigens encapsulated within biodegradable-biocompatible microspheres
|
US6217911B1
(en)
|
1995-05-22 |
2001-04-17 |
The United States Of America As Represented By The Secretary Of The Army |
sustained release non-steroidal, anti-inflammatory and lidocaine PLGA microspheres
|
US6309669B1
(en)
*
|
1984-03-16 |
2001-10-30 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive materials encapsulated within a biodegradable-biocompatible polymeric matrix
|
DE3428372A1
(de)
*
|
1984-08-01 |
1986-02-13 |
Hoechst Ag, 6230 Frankfurt |
Mikrokapseln von regulatorischen peptiden mit kontrollierter freisetzung, verfahren zu ihrer herstellung und injektionszubereitungen
|
CH660302A5
(fr)
*
|
1984-10-17 |
1987-04-15 |
Debiopharm Sa |
Procede de micro-encapsulation en phase heterogene de substances medicamenteuses hydrosolubles.
|
JP2551756B2
(ja)
*
|
1985-05-07 |
1996-11-06 |
武田薬品工業株式会社 |
ポリオキシカルボン酸エステルおよびその製造法
|
US4666704A
(en)
*
|
1985-05-24 |
1987-05-19 |
International Minerals & Chemical Corp. |
Controlled release delivery system for macromolecules
|
US5169633A
(en)
*
|
1985-07-29 |
1992-12-08 |
American Cyanamid Company |
Continuous release phenylethanolamine derivative compositions
|
US5059422A
(en)
*
|
1985-07-29 |
1991-10-22 |
American Cyanamid Company |
Continuous release phenylethanolamine derivative compositions
|
US5137874A
(en)
*
|
1985-07-29 |
1992-08-11 |
American Cyanamid Co. |
Partially coated C10 -C20 fatty acid salts of peptides having molecular weights up to about 5,000
|
CH669506A5
(en)
*
|
1986-01-13 |
1989-03-31 |
Hugo Degen |
Oscillating and reclining furniture
|
US4959217A
(en)
*
|
1986-05-22 |
1990-09-25 |
Syntex (U.S.A.) Inc. |
Delayed/sustained release of macromolecules
|
US4962091A
(en)
*
|
1986-05-23 |
1990-10-09 |
Syntex (U.S.A.) Inc. |
Controlled release of macromolecular polypeptides
|
JP2526589B2
(ja)
*
|
1986-08-08 |
1996-08-21 |
武田薬品工業株式会社 |
ペプチド含有マイクロカプセルおよびその製造法
|
US6024983A
(en)
*
|
1986-10-24 |
2000-02-15 |
Southern Research Institute |
Composition for delivering bioactive agents for immune response and its preparation
|
ES2102347T3
(es)
|
1987-02-20 |
1997-08-01 |
Genentech Inc |
Metodos y composiciones para la utilizacion de polipeptidos env y anticuerpos anti-env de hiv.
|
US5028430A
(en)
*
|
1987-05-08 |
1991-07-02 |
Syntex (U.S.A.) Inc. |
Delivery systems for the controlled administration of LHRH analogs
|
US5000886A
(en)
*
|
1987-05-26 |
1991-03-19 |
American Cyanamid Company |
Silicone-hardened pharmaceutical microcapsules and process of making the same
|
US4897268A
(en)
*
|
1987-08-03 |
1990-01-30 |
Southern Research Institute |
Drug delivery system and method of making the same
|
US5212154A
(en)
*
|
1987-08-14 |
1993-05-18 |
Akzo N.V. |
Preparation for treating complications in diabetes
|
GB2209937B
(en)
*
|
1987-09-21 |
1991-07-03 |
Depiopharm S A |
Water insoluble polypeptides
|
WO1989003678A1
(en)
*
|
1987-10-30 |
1989-05-05 |
Stolle Research & Development Corporation |
Low residual solvent microspheres and microencapsulation process
|
DE3738228A1
(de)
*
|
1987-11-11 |
1989-05-24 |
Hoechst Ag |
Verfahren zur herstellung von bioabbaubaren mikrokapseln wasserloeslicher peptide und proteine sowie nach diesem verfahren erhaltene mikrokapseln
|
DE3744329A1
(de)
*
|
1987-12-28 |
1989-07-06 |
Schwarz Pharma Gmbh |
Verfahren zur herstellung einer mindestens einen wirkstoff und einen traeger umfassenden zubereitung
|
US5271945A
(en)
*
|
1988-07-05 |
1993-12-21 |
Takeda Chemical Industries, Ltd. |
Sustained release microcapsule for water soluble drug
|
HU221294B1
(en)
*
|
1989-07-07 |
2002-09-28 |
Novartis Ag |
Process for producing retarde compositions containing the active ingredient in a polymeric carrier
|
PH30995A
(en)
*
|
1989-07-07 |
1997-12-23 |
Novartis Inc |
Sustained release formulations of water soluble peptides.
|
US5538739A
(en)
*
|
1989-07-07 |
1996-07-23 |
Sandoz Ltd. |
Sustained release formulations of water soluble peptides
|
ZA905327B
(en)
*
|
1989-07-07 |
1992-03-25 |
Sandoz Ltd |
Sustained release formulations of water soluble peptides
|
CH679207A5
(nl)
*
|
1989-07-28 |
1992-01-15 |
Debiopharm Sa |
|
US5439688A
(en)
*
|
1989-07-28 |
1995-08-08 |
Debio Recherche Pharmaceutique S.A. |
Process for preparing a pharmaceutical composition
|
US5225205A
(en)
*
|
1989-07-28 |
1993-07-06 |
Debiopharm S.A. |
Pharmaceutical composition in the form of microparticles
|
US5084443A
(en)
*
|
1989-12-04 |
1992-01-28 |
Biomeasure, Inc. |
Promoting expression of acetylcholine receptors with lhrh antagonist
|
JP2653255B2
(ja)
|
1990-02-13 |
1997-09-17 |
武田薬品工業株式会社 |
長期徐放型マイクロカプセル
|
MY107937A
(en)
*
|
1990-02-13 |
1996-06-29 |
Takeda Chemical Industries Ltd |
Prolonged release microcapsules.
|
US6353030B1
(en)
|
1990-08-01 |
2002-03-05 |
Novartis Ag |
Relating to organic compounds
|
NZ240214A
(en)
*
|
1990-10-16 |
1993-02-25 |
Takeda Chemical Industries Ltd |
Polymer compositions comprising a polylactic acid and a copolymer of glycolic acid and a hydroxycarboxylic acid; use as carrier for prolonged release pharmaceutical compositions of water soluble drugs
|
IT1243390B
(it)
*
|
1990-11-22 |
1994-06-10 |
Vectorpharma Int |
Composizioni farmaceutiche in forma di particelle atte al rilascio controllato di sostanze farmacologicamente attive e procedimento per la loro preparazione.
|
DE4041563A1
(de)
*
|
1990-12-22 |
1992-06-25 |
Sanol Arznei Schwarz Gmbh |
Verfahren zur herstellung wirkstoffhaltiger mikropartikel aus hydrolytisch abbaubaren polymeren
|
AU8303691A
(en)
|
1991-04-24 |
1992-12-21 |
United States Of America, As Represented By The Secretary Of The Army, The |
Oral-intestinal vaccines against diseases caused by enteropathogenic organisms using antigens encapsulated within biodegradable-biocompatible microspheres
|
CH683149A5
(fr)
*
|
1991-07-22 |
1994-01-31 |
Debio Rech Pharma Sa |
Procédé pour la préparation de microsphères en matériau polymère biodégradable.
|
EP0612348B1
(en)
|
1991-11-04 |
2003-04-23 |
Genetics Institute, LLC |
Recombinant bone morphogenetic protein heterodimers, compositions and methods of use
|
US6005067A
(en)
*
|
1992-01-24 |
1999-12-21 |
Cargill Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5258488A
(en)
*
|
1992-01-24 |
1993-11-02 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247058A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US5247059A
(en)
*
|
1992-01-24 |
1993-09-21 |
Cargill, Incorporated |
Continuous process for the manufacture of a purified lactide from esters of lactic acid
|
US5142023A
(en)
*
|
1992-01-24 |
1992-08-25 |
Cargill, Incorporated |
Continuous process for manufacture of lactide polymers with controlled optical purity
|
US6326458B1
(en)
|
1992-01-24 |
2001-12-04 |
Cargill, Inc. |
Continuous process for the manufacture of lactide and lactide polymers
|
US5656297A
(en)
*
|
1992-03-12 |
1997-08-12 |
Alkermes Controlled Therapeutics, Incorporated |
Modulated release from biocompatible polymers
|
GB9211268D0
(en)
*
|
1992-05-28 |
1992-07-15 |
Ici Plc |
Salts of basic peptides with carboxyterminated polyesters
|
DE4223169C1
(de)
|
1992-07-10 |
1993-11-25 |
Ferring Arzneimittel Gmbh |
Verfahren zur Mikroverkapselung wasserlöslicher Wirkstoffe
|
JP2651320B2
(ja)
*
|
1992-07-16 |
1997-09-10 |
田辺製薬株式会社 |
徐放性マイクロスフェア製剤の製造方法
|
EP0595030A3
(en)
*
|
1992-10-01 |
1995-06-07 |
Tanabe Seiyaku Co |
Composition of microspheres with several delayed release nuclei and its preparation process.
|
JP3447289B2
(ja)
*
|
1992-10-02 |
2003-09-16 |
カーギル, インコーポレイテッド |
溶融安定性ラクチドポリマー繊維及びその製造方法
|
US5338822A
(en)
*
|
1992-10-02 |
1994-08-16 |
Cargill, Incorporated |
Melt-stable lactide polymer composition and process for manufacture thereof
|
US6005068A
(en)
*
|
1992-10-02 |
1999-12-21 |
Cargill Incorporated |
Melt-stable amorphous lactide polymer film and process for manufacture thereof
|
CA2124845C
(en)
*
|
1992-10-02 |
2005-07-26 |
Patrick R. Gruber |
Paper having a melt-stable lactide polymer coating and process for manufacture thereof
|
UA61046C2
(en)
|
1992-12-07 |
2003-11-17 |
Takeda Chemical Industries Ltd |
Sustained-release preparation and method for its manufacture
|
TW333456B
(en)
|
1992-12-07 |
1998-06-11 |
Takeda Pharm Ind Co Ltd |
A pharmaceutical composition of sustained-release preparation the invention relates to a pharmaceutical composition of sustained-release preparation which comprises a physiologically active peptide.
|
US6939546B2
(en)
|
1993-05-21 |
2005-09-06 |
The United States Of America As Represented By The Secretary Of The Army |
Model for testing immunogenicity of peptides
|
US6440457B1
(en)
|
1993-05-27 |
2002-08-27 |
Alza Corporation |
Method of administering antidepressant dosage form
|
US6087324A
(en)
|
1993-06-24 |
2000-07-11 |
Takeda Chemical Industries, Ltd. |
Sustained-release preparation
|
JP3822232B2
(ja)
|
1993-08-30 |
2006-09-13 |
ベイラー・カレッジ・オブ・メディシン |
老化細胞由来dna合成阻害因子
|
PT729357E
(pt)
|
1993-11-19 |
2005-06-30 |
Janssen Pharmaceutica Nv |
1,2-bwenzazoles microencapsulados
|
FR2713933B1
(fr)
*
|
1993-12-16 |
1996-02-02 |
Rhone Merieux |
Méthode de superovulation des femelles bovines, méthode de mise en anoestrus et kit approprié.
|
US6447796B1
(en)
|
1994-05-16 |
2002-09-10 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6855331B2
(en)
|
1994-05-16 |
2005-02-15 |
The United States Of America As Represented By The Secretary Of The Army |
Sustained release hydrophobic bioactive PLGA microspheres
|
US6117455A
(en)
*
|
1994-09-30 |
2000-09-12 |
Takeda Chemical Industries, Ltd. |
Sustained-release microcapsule of amorphous water-soluble pharmaceutical active agent
|
US6902743B1
(en)
|
1995-05-22 |
2005-06-07 |
The United States Of America As Represented By The Secretary Of The Army |
Therapeutic treatment and prevention of infections with a bioactive material(s) encapuslated within a biodegradable-bio-compatable polymeric matrix
|
US7033608B1
(en)
|
1995-05-22 |
2006-04-25 |
The United States Of America As Represented By The Secretary Of The Army |
“Burst-free” sustained release poly-(lactide/glycolide) microspheres
|
US5599535A
(en)
*
|
1995-06-07 |
1997-02-04 |
Regents Of The University Of California |
Methods for the cyto-protection of the trabecular meshwork
|
US5674888A
(en)
*
|
1995-06-07 |
1997-10-07 |
University Of California |
Method for the treatment of a trabecular meshwork whose cells are subject to inhibition of cell division
|
US5877224A
(en)
*
|
1995-07-28 |
1999-03-02 |
Rutgers, The State University Of New Jersey |
Polymeric drug formulations
|
US6020473A
(en)
|
1995-08-25 |
2000-02-01 |
Genentech, Inc. |
Nucleic acids encoding variants of vascular endothelial cell growth factor
|
US7005505B1
(en)
|
1995-08-25 |
2006-02-28 |
Genentech, Inc. |
Variants of vascular endothelial cell growth factor
|
CA2192773C
(en)
|
1995-12-15 |
2008-09-23 |
Hiroaki Okada |
Production of sustained-release preparation for injection
|
EP0817619A4
(en)
*
|
1996-01-24 |
1999-02-03 |
Us Army |
NEW POLY- (LACTIDE / GLUCOLIDE) MICROSPHERES WITH EXTENDED RELEASE "WITHOUT BREAKING"
|
US6100071A
(en)
|
1996-05-07 |
2000-08-08 |
Genentech, Inc. |
Receptors as novel inhibitors of vascular endothelial growth factor activity and processes for their production
|
US6218542B1
(en)
|
1996-10-15 |
2001-04-17 |
Jenssen Pharmaceutica N.V. |
Synthesis of cisapride
|
ATE272394T1
(de)
|
1996-10-31 |
2004-08-15 |
Takeda Chemical Industries Ltd |
Zubereitung mit verzögerter freisetzung
|
US6171788B1
(en)
|
1997-01-28 |
2001-01-09 |
The Regents Of The University Of California |
Methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US7138511B1
(en)
|
1997-01-28 |
2006-11-21 |
The Regents Of The University Of California |
Nucleic acids, kits and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
US6475724B1
(en)
|
1997-01-28 |
2002-11-05 |
The Regents Of The University Of California |
Nucleic acids, kits, and methods for the diagnosis, prognosis and treatment of glaucoma and related disorders
|
SE512663C2
(sv)
*
|
1997-10-23 |
2000-04-17 |
Biogram Ab |
Inkapslingsförfarande för aktiv substans i en bionedbrytbar polymer
|
NZ525914A
(en)
|
1998-03-10 |
2004-03-26 |
Genentech Inc |
Novel polypeptides and nucleic acids encoding the same
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
DE10008880A1
(de)
*
|
1999-02-19 |
2000-08-24 |
Bioserv Ag |
Bioabbaubare Komposite zur Herstellung von Mikrokapseln
|
US7078382B1
(en)
|
1999-11-02 |
2006-07-18 |
Genentech, Inc. |
Modulation of eNOS activity and therapeutic uses thereof
|
TWI284048B
(en)
|
2000-01-27 |
2007-07-21 |
Zentaris Ag |
Compressed microparticles for dry injection
|
JP5046447B2
(ja)
|
2000-08-07 |
2012-10-10 |
和光純薬工業株式会社 |
乳酸重合体及びその製造方法
|
US6824822B2
(en)
|
2001-08-31 |
2004-11-30 |
Alkermes Controlled Therapeutics Inc. Ii |
Residual solvent extraction method and microparticles produced thereby
|
US8470359B2
(en)
|
2000-11-13 |
2013-06-25 |
Qlt Usa, Inc. |
Sustained release polymer
|
WO2003000156A1
(en)
|
2001-06-22 |
2003-01-03 |
Southern Biosystems, Inc. |
Zero-order prolonged release coaxial implants
|
TW200526267A
(en)
|
2001-06-29 |
2005-08-16 |
Takeda Chemical Industries Ltd |
Controlled release composition and method of producing the same
|
US7615233B2
(en)
|
2001-07-10 |
2009-11-10 |
Canon Kabushiki Kaisha |
Particulate construct comprising polyhydroxyalkanoate and method for producing it
|
US20040191215A1
(en)
*
|
2003-03-25 |
2004-09-30 |
Michael Froix |
Compositions for induction of a therapeutic response
|
JP2004331750A
(ja)
|
2003-05-02 |
2004-11-25 |
Canon Inc |
ポリヒドロキシアルカノエートを含有する磁性構造体及びその製造方法ならびにその用途
|
WO2005025595A2
(en)
|
2003-09-12 |
2005-03-24 |
Wyeth |
Injectable calcium phosphate solid rods and pastes for delivery of osteogenic proteins
|
ATE531374T1
(de)
|
2004-04-15 |
2011-11-15 |
Alkermes Inc |
Vorrichtung auf polymerbasis mit verzögerter freisetzung
|
US7456254B2
(en)
|
2004-04-15 |
2008-11-25 |
Alkermes, Inc. |
Polymer-based sustained release device
|
NZ552298A
(en)
|
2004-05-23 |
2011-04-29 |
Gerard M Housey |
Method for identifying inhibitors or activators of a theramutein by comparing the phenoresponse of cells exposed to a test compound
|
CN101076314A
(zh)
*
|
2004-08-04 |
2007-11-21 |
克里纽沃药物有限公司 |
在对象体内诱导黑素生成的方法
|
ES2255426B1
(es)
|
2004-10-19 |
2007-08-16 |
Gp Pharm, S.A. |
Formulacion farmaceutica que comprende microcapsulas de estatinas suspendidas en ester alquilicos de acidos grasos poliinsaturados (pufa).
|
PL1824460T3
(pl)
*
|
2004-11-10 |
2015-09-30 |
Tolmar Therapeutics Inc |
Stabilizowany polimerowy układ dostarczania
|
US11246913B2
(en)
|
2005-02-03 |
2022-02-15 |
Intarcia Therapeutics, Inc. |
Suspension formulation comprising an insulinotropic peptide
|
US8431110B2
(en)
|
2005-05-23 |
2013-04-30 |
Hmi Medical Innovations, Llc. |
Compounds and method of identifying, synthesizing, optimizing and profiling protein modulators
|
KR101502920B1
(ko)
|
2005-06-21 |
2015-03-17 |
조마 (유에스) 엘엘씨 |
IL-1β 결합성 항체 및 그의 단편
|
JP5072057B2
(ja)
*
|
2005-08-22 |
2012-11-14 |
東ソー株式会社 |
微小流路構造体を用いたマイクロカプセルの製造方法
|
KR100722607B1
(ko)
|
2006-05-11 |
2007-05-28 |
주식회사 펩트론 |
분산성 및 주사 투여능이 향상된 서방성 미립구의 제조방법
|
EP3421031A1
(en)
|
2006-08-09 |
2019-01-02 |
Intarcia Therapeutics, Inc |
Osmotic delivery systems and piston assemblies
|
MY148370A
(en)
|
2006-12-18 |
2013-04-15 |
Takeda Pharmaceutical |
Sustained-release composition and method for producing the same
|
EP3124045A3
(en)
|
2006-12-20 |
2017-05-03 |
Xoma (Us) Llc |
Treatment of il-1 beta related diseases
|
KR101208381B1
(ko)
|
2007-04-23 |
2012-12-05 |
인타르시아 세라퓨틱스 인코포레이티드 |
인슐린자극 펩티드의 현탁 제형 및 이의 용도
|
CA2692171C
(en)
|
2007-06-22 |
2019-10-22 |
Randolph Watnick |
Methods and uses thereof of prosaposin
|
WO2011084685A2
(en)
|
2009-12-17 |
2011-07-14 |
Children's Medical Center Corporation |
Saposin-a derived peptides and uses thereof
|
EP2391650B1
(en)
|
2007-12-20 |
2014-10-15 |
Xoma (Us) Llc |
Methods for the treatment of gout
|
DK2240155T3
(da)
|
2008-02-13 |
2012-09-17 |
Intarcia Therapeutics Inc |
Indretninger, formuleringer og fremgangsmåder til levering af flere gavnlige midler
|
AU2010222648B2
(en)
|
2009-03-09 |
2016-07-07 |
Pronova Biopharma Norge As |
Compositions comprising a fatty acid oil mixture and a surfactant, and methods and uses thereof
|
WO2010144797A2
(en)
|
2009-06-12 |
2010-12-16 |
Vaccine Technologies, Incorporated |
Influenza vaccines with enhanced immunogenicity and uses thereof
|
EP2462246B1
(en)
|
2009-09-28 |
2017-09-06 |
Intarcia Therapeutics, Inc |
Rapid establishment and/or termination of substantial steady-state drug delivery
|
ES2363964B1
(es)
|
2009-11-20 |
2012-08-22 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados.
|
ES2363965B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm S.A. |
Cápsulas de principios activos betabloqueantes y ésteres de ácidos grasos poliinsaturados.
|
ES2364011B1
(es)
|
2009-11-20 |
2013-01-24 |
Gp Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ésteres de ácidos grasos poliinsaturados para el tratamiento de enfermedades cardiovasculares.
|
SG181446A1
(en)
|
2009-12-23 |
2012-07-30 |
Defiante Farmaceutica Sa |
Combination composition useful for treating cardiovascular diseases
|
JP2013525271A
(ja)
|
2010-03-12 |
2013-06-20 |
チルドレンズ メディカル センター コーポレーション |
免疫原およびそのスクリーニング方法
|
ES2383271B1
(es)
|
2010-03-24 |
2013-08-01 |
Lipotec S.A. |
Procedimiento de tratamiento de fibras y/o materiales textiles
|
US9993019B2
(en)
|
2010-03-26 |
2018-06-12 |
Philip Morris Usa Inc. |
Method for making particle of a hydrophobic additive and a polysaccharide coating and tobacco products containing particle of a hydrophobic additive and a polysaccharide coating
|
CN104203275A
(zh)
|
2010-06-09 |
2014-12-10 |
疫苗技术股份有限公司 |
用于增强抗逆转录病毒治疗的hiv感染者的治疗性免疫
|
ES2385240B1
(es)
|
2010-07-26 |
2013-09-23 |
Gp-Pharm, S.A. |
Cápsulas de principios activos farmacéuticos y ácidos grasos poliinsaturados para el tratamiento de enfermedades de la próstata.
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
US20120208755A1
(en)
|
2011-02-16 |
2012-08-16 |
Intarcia Therapeutics, Inc. |
Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
|
EP3912619A1
(en)
|
2011-05-11 |
2021-11-24 |
Children's Medical Center Corporation |
Modified biotin-binding protein, fusion proteins thereof and applications
|
WO2013028541A1
(en)
|
2011-08-19 |
2013-02-28 |
Children's Medical Center Corporation |
Vegf-binding protein for blockade of angiogenesis
|
DE102011114864A1
(de)
*
|
2011-10-05 |
2013-04-11 |
Acino Ag |
Verfahren zur Herstellung einer homogenen Pulvermischung und Verfahren zur Herstellung eines Implantats sowie Implantat
|
WO2013072767A1
(en)
|
2011-11-18 |
2013-05-23 |
Pronova Biopharma Norge As |
Compositions and preconcentrates comprising at least one salicylate and omega-3 fatty acid oil mixture
|
CN102511790B
(zh)
*
|
2011-12-05 |
2013-07-24 |
山东好当家海洋发展股份有限公司 |
一种水产蛋白肽微胶囊的制备方法
|
CN102488619B
(zh)
|
2011-12-05 |
2014-08-06 |
上海交通大学 |
连续生产艾塞那肽微球的装置及控制微球释放速度的方法
|
EP3050900A1
(en)
|
2011-12-19 |
2016-08-03 |
Xoma (Us) Llc |
Methods for treating acne
|
AU2012358269B2
(en)
|
2011-12-22 |
2017-11-02 |
Children's Medical Center Corporation |
Saposin-A derived peptides and uses thereof
|
AU2013208003B2
(en)
|
2012-01-09 |
2017-12-14 |
The Scripps Research Institute |
Ultralong complementarity determining regions and uses thereof
|
EP3663314A1
(en)
|
2012-01-09 |
2020-06-10 |
The Scripps Research Institute |
Humanized antibodies with ultralong cdr3s
|
ES2606392T3
(es)
|
2012-04-04 |
2017-03-23 |
Pronova Biopharma Norge As |
Composiciones que comprenden ácidos grasos omega-3 y vitamina D para acné vulgar y/o eccema, y procedimientos y usos de las mismas
|
WO2013150384A1
(en)
|
2012-04-04 |
2013-10-10 |
Pronova Biopharma Norge As |
Compositions comprising omega-3 fatty acids and vitamin d for psoriasis, and methods and uses thereof
|
CA2900008A1
(en)
|
2013-02-07 |
2014-08-14 |
Children's Medical Center Corporation |
Protein antigens that provide protection against pneumococcal colonization and/or disease
|
JP6537980B2
(ja)
|
2013-02-28 |
2019-07-03 |
プロノヴァ・バイオファーマ・ノルゲ・アーエスPronova BioPharma Norge AS |
脂質化合物、トリグリセリドおよび界面活性剤を含む組成物、ならびにその使用方法
|
WO2015010100A2
(en)
|
2013-07-18 |
2015-01-22 |
Fabrus, Inc. |
Humanized antibodies with ultralong complementarity determining regions
|
EP3022224A2
(en)
|
2013-07-18 |
2016-05-25 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
AU2014318579A1
(en)
|
2013-09-13 |
2016-04-14 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
US20150238631A1
(en)
|
2013-10-15 |
2015-08-27 |
The California Institute For Biomedical Research |
Chimeric antigen receptor t cell switches and uses thereof
|
AU2014337367B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Peptidic chimeric antigen receptor T cell switches and uses thereof
|
EP4212180A1
(en)
|
2013-12-18 |
2023-07-19 |
The Scripps Research Institute |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
EP2977758A1
(en)
|
2014-07-24 |
2016-01-27 |
Université De Nice Sophia Antipolis |
Methods and kits for monitoring membranous nephropathy
|
US9889085B1
(en)
|
2014-09-30 |
2018-02-13 |
Intarcia Therapeutics, Inc. |
Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
|
WO2016154621A1
(en)
|
2015-03-26 |
2016-09-29 |
The California Institute For Biomedical Research |
SWITCHABLE NON-scFv CHIMERIC RECEPTORS, SWITCHES, AND USES THEREOF
|
EP3283113A4
(en)
|
2015-04-15 |
2018-12-05 |
The California Institute for Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
CN107921098A
(zh)
|
2015-06-17 |
2018-04-17 |
加州生物医学研究所 |
修饰的治疗剂及其组合物
|
AU2017268161B2
(en)
|
2016-05-16 |
2020-03-12 |
Intarcia Therapeutics, Inc. |
Glucagon-receptor selective polypeptides and methods of use thereof
|
EP3529268A1
(en)
|
2016-10-19 |
2019-08-28 |
The Scripps Research Institute |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
|
CN110225762A
(zh)
|
2017-01-03 |
2019-09-10 |
因塔西亚制药公司 |
包括glp-1受体激动剂的连续施用和药物的共同施用的方法
|
MX2020003681A
(es)
|
2017-09-26 |
2020-08-03 |
Nanomi B V |
Metodo para preparar microparticulas por tecnica de doble emulsion.
|
US20210047425A1
(en)
|
2019-08-12 |
2021-02-18 |
Purinomia Biotech, Inc. |
Methods and compositions for promoting and potentiating t-cell mediated immune responses through adcc targeting of cd39 expressing cells
|
CN110585170A
(zh)
*
|
2019-09-17 |
2019-12-20 |
南京赛弗斯医药科技有限公司 |
一种采用3d打印制备的醋酸特利加压素注射用缓释微球及其制备方法
|
EP4048405A2
(en)
|
2019-10-24 |
2022-08-31 |
Minotaur Therapeutics, Inc. |
Chimeric cytokine modified antibodies and methods of use thereof
|
US20230098350A1
(en)
|
2019-12-31 |
2023-03-30 |
Guangzhou Diqi Pharmaceuticals Co., Ltd . |
Tertiary amine pharmaceutical composition and industrialized batch preparation method thereof
|
WO2022232321A1
(en)
|
2021-04-28 |
2022-11-03 |
Minotaur Therapeutics, Inc. |
Humanized chimeric bovine antibodies and methods of use
|